Testing Metformin for Weight Loss in Obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether metformin, a common diabetes medicine, can help people with obesity lose weight. It is for people who do not have diabetes and have not used weight loss treatments in the past year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are considered obese (BMI of 30 or higher).
- Your blood sugar is below a certain level (no diabetes).
- You have not used any medical or supervised weight loss program in the last 12 months.
- You are not currently enrolled in any other clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding fiber to metformin helps teens with severe obesity and insulin resistance improve how their bodies handle sugar. You might consider it if you’re a teen who isn’t yet diagnosed with type 2 diabetes and meets the specific lab and health criteria.
This trial tests whether the diabetes drug metformin can help people with asthma who are also overweight or obese. The goal is to see if it improves asthma control and reduces the need for rescue medications.
This trial tests whether adding metformin (a diabetes medicine) to usual antidepressant treatment can help improve depression in people who are overweight or obese. It is for adults age 18–44 who are newly diagnosed with depression and do not have diabetes.
This study tests two investigational medications, MET233 and MET097, in people with obesity or overweight, with or without type 2 diabetes. It aims to see if the combination can help with weight loss and blood sugar control.
This trial compares a new drug, TriGlytza-01, to metformin in people with type 2 diabetes who are overweight or obese and whose blood sugar isn't well controlled despite taking metformin. The goal is to see if the new drug works better at improving blood sugar and weight.
This trial tests if adding metformin to antidepressants helps people who have both depression and obesity. It also looks at genetic factors that might affect treatment response.
Hear when a new Obesity and Cardiovascular Risk trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.